Prospects for a mucosally-administered vaccine against Helicobacter pylori

By Svennerholm A.-M.  

Vaccine, Vol. 21, Iss. 5, 2003-01 ,pp. : 347-353

Elsevier

Access to resources Recommend Favorite

Immunogenicity of a recombinant varicella-zoster virus gE-IE63 fusion protein, a putative vaccine candidate against primary infection and zoster reactivation

By Jacquet A.   Haumont M.   Massaer M.   Garcia L.   Mazzu P.   Daminet V.   Gregoire D.   Jacobs P.   Bollen A.  

Vaccine, Vol. 20, Iss. 11, 2002-02 ,pp. : 1593-1602

Elsevier

Access to resources Recommend Favorite

Protection against experimental bubonic and pneumonic plague by a recombinant capsular F1-V antigen fusion protein vaccine

By Heath D.G.   Anderson G.W.   Mauro J.M.   Welkos S.L.   Andrews G.P.   Adamovicz J.   Friedlander A.M.  

Vaccine, Vol. 16, Iss. 11, 1998-07 ,pp. : 1131-1137

Elsevier

Access to resources Recommend Favorite

An experimental bivalent peptide vaccine against schistosomiasis and fascioliasis

By Vilar M.M.   Barrientos F.   Almeida M.   Thaumaturgo N.   Simpson A.   Garratt R.   Tendler M.  

Vaccine, Vol. 22, Iss. 1, 2003-12 ,pp. : 137-144

Elsevier

Access to resources Recommend Favorite

Development of a replication-deficient recombinant vaccinia virus vaccine effective against parainfluenza virus 3 infection in an animal model

By Wyatt L.S.   Shors S.T.   Murphy B.R.   Moss B.  

Vaccine, Vol. 14, Iss. 15, 1996-10 ,pp. : 1451-1458

Elsevier

Access to resources Recommend Favorite